New blood test gives very high accuracy to screen for Alzheimer’s disease. A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the earliest pathology.